Found 53 matching trials
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer PHASE3 The purpose of this study is to evaluate the efficacy and safety (including...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel PHASE2 The purpose of this study is to investigate the safety and efficacy of abir...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer PHASE2 The purpose of this study is to evaluate the serum testosterone levels in p...
Show More Location
Alliance Research
Learn More & Join Trial
Neo-adjuvant Abiraterone Prostate Study PHASE2 The role of this study is to focus on the potential role of abiraterone ace...
Show More Location
Cork University Hospital
Learn More & Join Trial
Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients PHASE4 The purpose of this study is to determine if continued treatment with Enzal...
Show More Location
Beth Israel Deaconess Medical Center
Learn More & Join Trial
Abiraterone Acetate in Patients With Relapsed and/or Metastatic Salivary Gland Cancers PHASE2 Carcinomas of the salivary glands (SGCs) are rare tumors. Some selected sal...
Show More Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Learn More & Join Trial
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer PHASE2 Hormone therapy, or androgen deprivation therapy (ADT) is a standard way to...
Show More Location
Clearview Cancer Institute
Learn More & Join Trial
Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination) N/A The purpose of this pre-approval access is to provide Niraparib plus Abirat...
Show More Status
Approved For Marketing
Location
Multiple Locations
Learn More & Join Trial
RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer) PHASE4 Researchers in this study want to compare how well drug radium-223 dichlori...
Show More Status
Active Not Recruiting
Location
Specialist Services Medical Group
Learn More & Join Trial
Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate PHASE2 Neoadjuvant treatment before radical prostatectomy has been proven to provi...
Show More Location
West China Hospital
Learn More & Join Trial